The role of adrenal scintigraphy in the preoperative management of primary aldosteronism

Scandinavian Journal of Surgery

Volumn 97, Issue 3, 2008, Pages 248-253

  Volpe, C ^a,b   Enberg, U ^a   Sjogren A ^a   Wahrenberg, H ^a   Jacobsson, H ^a   Torring O ^b   Hamberger, Bertil ^a   Thoren M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adrenal imaging; Adrenal surgery; Adrenalectomy; Aldosterone producing adenoma; Aldosteronism; Scintigraphy

Indexed keywords

6BETA IODOMETHYL 19 NORCHOLEST 5(10) EN 3BETA OL I 131; DEXAMETHASONE;

ADRENAL HYPERPLASIA; ADRENAL SCINTISCANNING; ADRENALECTOMY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; MALE; PREOPERATIVE CARE; PRIMARY HYPERALDOSTERONISM; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 53849118504     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690809700308     Document Type: Article

References (24)

1. Stowasser M, Gordon RD: Primary aldosteronism. Best Pract Res Clin Endocrinol Metab 2003;17:591-605
2. Patel SM, Lingam RK, Beaconsfield TI, Tran TL, Brown B: Role of radiology in the management of primary aldosteronism. Radiographics 2007;27:1145-1157
3. Beierwaltes WH, Lieberman LM, Ansari AN, Nishiyama H: 131 I-19-iodocholesterol in the diagnosis of adrenal disease. J Lab Clin Med 1971;78:986-987
4. Sarkar SD, Beierwaltes H, Ice RD, Basmadjian GP, Hetzel KR, Kennedy WP, Mason MM: A new and superior adrenal scanning agent, NP-59. J Nucl Med 1975;16:1038-1042
5. Freitas JE, Grekin RJ, Thrall JH, Gross MD, Swanson DP, Beierwaltes WH: Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism. J Nucl Med 1979;20:7-10
6. Avram AM, Fig LM, Gross MD: Adrenal gland scintigraphy. Semin Nucl Med 2006;36:212-227
7. Hwang I, Balingit AG, Georgitis Wj, Sisson JC, Shapiro B: Adrenocortical SPECT using iodine-131 NP-59. J Nucl Med 1998;39:1460-1463
8. Rubello D, Bui C, Casara D, Gross MD, Fig LM, Shapiro B: Functional scintigraphy of the adrenal gland. Eur J Endocrinol 2002;147:13-28
9. Ishimura J, Kawanaka M, Fukuchi M: Clinical application of SPECT in adrenal imaging with iodine-131 6 beta-iodomethyl-19-norcholesterol. Clin Nucl Med 1989;14:278-281
10. Enberg U, Volpe C, Höög A, Wedell A, Farnebo LO, Thorén M, Hamberger B: Postoperative differentiation between unilateral adrenal adenoma and bilateral adrenal hyperplasia in primary aldosteronism by mRNA expression of the gene CYP11B2. Eur J Endocrinol 2004;151:73-85
11. Enberg U, Volpe C, Hamberger B: New aspects on primary aldosteronism. Neurochem Res 2003;28:327-332
12. Nocaudie-Calzada M, Huglo D, Lambert M, Ernst O, Proye C, Wemeau JL, Marchandise X: Efficacy of iodine-131 6beta-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronism. Eur J Nucl Med 1999;26:1326-1332
13. Chang LT: A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;25:638-643
14. Young WF: Minireview: primary aldosteronism--changing concepts in diagnosis and treatment. Endocrinology 2003;144:2208-2213
15. Rossi GP, Bernini G, Cahurni C, Desideri G, Fabris B, Ferri C, Ganzaroli C Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F; PAPY Study Investigators: A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006;48:2293-2300
16. Enberg U, Farnebo LO, Wedell A, Gröndal S, Thorén M, Grimelius L, Kjellman M, Bäckdahl M, Hamberger B: In vitro release of aldosterone and cortisol in human adrenal adenomas correlates to mRNA expression of steroidogenic enzymes for genes CYP11B2 and CYP17. World J Surg 2001;25:957-966
17. Lumachi F, Marzola MC, Zucchetta P, Tregnaghi A, Cecchin D, Favia G, Bui F: Non-invasive adrenal imaging in primary aldosteronism. Sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI. Nucl Med Commun 2003;24:683-688
18. Nomura K, Kusakabe K, Maki M, Ito Y, Aiba M, Demura H: Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: relationship to adenoma size and functional activity. J Clin Endocrinol Metab 1990;71:825-830
19. Zettinig G, Mitterhauser M, Wadsak W, Becherer A, Pirich C, Vierhapper H, Niederle B, Dudczak R, Kletter K: Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate. Eur J Nucl Med Mol Imaging 2004;31:1224-1230
20. Hennings J, Lindhe O, Bergström M, Langström B, Sundin A, Hellman P: [11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings. J Clin Endocrinol Metab 2006;91:1410-1414
21. Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA: Role for adrenal venous sampling in primary aldosteronism. Surgery 2004;136:1227-1235
22. Rossi GP, Sacchetto A, Chiesura-Corona M, De Toni R, Gallina M, Feltrin GP, Pessina AC: Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 2001;86:1083-1090
23. Young WF, Klee GG: Primary aldosteronism. Diagnostic evaluation. Endocrinol Metab Clin North Am 1988;17:367-395
24. Mattsson C, Young WF: Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol 2006;2:198-208